Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-High Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06764238
What this trial is testing

Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

Who this might be right for
Acute Lymphoblastic Leukemia ALLChildhood Leukemia, Acute LymphoblasticB Cell Acute Lymphoblastic Leukemia (B-ALL)
Institute of Hematology & Blood Diseases Hospital, China 1,800
Not applicableStudy completedNCT07749027
What this trial is testing

Comparison Between Low-Dose and High-Dose Nepafenac Sodium

Who this might be right for
Cataract
Muhammad Aamir Latif 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT02923180
What this trial is testing

Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33
Not applicableStudy completedNCT07374978
What this trial is testing

Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk

Who this might be right for
Pulmonary Embolism Subacute MassiveThrombolytic Therapy
Ain Shams University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07137884
What this trial is testing

Anlotinib Hydrochloride Capsules in Maintenance Treatment for Intermediate-High Risk Rhabdomyosarcoma in Children

Who this might be right for
Rhabdomyosarcoma RecurrentMaintenance Treatment
Sun Yat-sen University 150
Early research (Phase 1)Study completedNCT02107235
What this trial is testing

Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
Traws Pharma, Inc. 2
Not applicableNot Yet RecruitingNCT06006195
What this trial is testing

Investigating the Correlations Between Dysphagia Symptoms and Swallowing Muscle Groups by HRPM-I

Who this might be right for
Swallowing Contraction Strength
National Taiwan University Hospital 50
Not applicableStudy completedNCT01985828
What this trial is testing

CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Wake Forest University Health Sciences 83
Not applicableLooking for participantsNCT05792150
What this trial is testing

PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS

Who this might be right for
Female Breast Cancer
Women's Cancer Study Group GmbH 1,470
Not applicableLooking for participantsNCT07372131
What this trial is testing

Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients

Who this might be right for
Bloodstream InfectionGram Negative InfectionsBacteraemia Caused by Gram-Negative Bacteria+1 more
Valeria Cento 172
Not applicableLooking for participantsNCT06701474
What this trial is testing

Comparison of Functional Recovery After Total Knee Arthroplasty Between Low Phase Angle and High Phase Angle Group

Who this might be right for
Knee Osteoarthritis
Yonsei University 200
Testing effectiveness (Phase 2)Study completedNCT02777385
What this trial is testing

Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Dan Zandberg 80
Large-scale testing (Phase 3)Looking for participantsNCT06453876
What this trial is testing

Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)

Who this might be right for
Pulmonary Embolism
Jesper Kjaergaard 210
Post-approval studies (Phase 4)UnknownNCT02769689
What this trial is testing

Methylprednisolone During the Switch Between Natalizumab and Fingolimod

Who this might be right for
Multiple Sclerosis
University Hospital, Clermont-Ferrand 56
Large-scale testing (Phase 3)UnknownNCT05175508
What this trial is testing

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

Who this might be right for
AMLMDSOld Age; Debility+1 more
The First Affiliated Hospital of Soochow University 180
Large-scale testing (Phase 3)UnknownNCT02281708
What this trial is testing

Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma

Who this might be right for
Stage Ib Lung Carcinoma
Seoul National University Hospital 1,012
Early research (Phase 1)Active Not RecruitingNCT04147806
What this trial is testing

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Albert Einstein College of Medicine 31
Testing effectiveness (Phase 2)Study completedNCT00559104
What this trial is testing

Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 60
Not applicableEnded earlyNCT04412070
What this trial is testing

Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients

Who this might be right for
Bladder Cancer
Hopital Foch 20
Large-scale testing (Phase 3)Looking for participantsNCT02416388
What this trial is testing

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Angers 3,100
Next Page